GPO Plus Inc (GPOX) reported Q3 2025 revenue of $1.2316 million, up 13.1% year-over-year and 3.6% quarter-over-quarter, reflecting continued top-line momentum in its niche of industry-specific group purchasing organizations (GPOs) for healthcare, hemp (cbdGPO), and related professional services. Despite better revenue and a narrowing of the operating loss, the company remains unprofitable on a net basis and carries material liquidity and balance-sheet stresses. The quarter showed improving EBITDA (still negative at $-0.251 million) and a reduced net loss of $-0.409 million, but cash burn persisted with negative free cash flow of $-0.359 million and cash at period-end of only $9.8k. The mix of growth in revenue with continued inefficiencies highlights a path to profitability only if scale, cost controls, and working capital efficiency improve meaningfully. Management commentary (where available) suggests ongoing focus on leveraging HealthGPO and cbdGPO as engines for deeper customer relationships and higher-margin services, but explicit forward guidance remained limited in the provided materials. The balance sheet remains structurally levered, with current ratio ~0.044 and stockholders’ equity deeply negative, signaling a high-risk investment profile until operating leverage and liquidity are meaningfully improved.